Your browser doesn't support javascript.
loading
Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.
Zhao, Ling-Hao; Liu, Xiao; Yan, He-Xin; Li, Wei-Yang; Zeng, Xi; Yang, Yuan; Zhao, Jie; Liu, Shi-Ping; Zhuang, Xue-Han; Lin, Chuan; Qin, Chen-Jie; Zhao, Yi; Pan, Ze-Ya; Huang, Gang; Liu, Hui; Zhang, Jin; Wang, Ruo-Yu; Yang, Yun; Wen, Wen; Lv, Gui-Shuai; Zhang, Hui-Lu; Wu, Han; Huang, Shuai; Wang, Ming-Da; Tang, Liang; Cao, Hong-Zhi; Wang, Ling; Lee, Tin-Lap; Jiang, Hui; Tan, Ye-Xiong; Yuan, Sheng-Xian; Hou, Guo-Jun; Tao, Qi-Fei; Xu, Qin-Guo; Zhang, Xiu-Qing; Wu, Meng-Chao; Xu, Xun; Wang, Jun; Yang, Huan-Ming; Zhou, Wei-Ping; Wang, Hong-Yang.
Afiliación
  • Zhao LH; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Liu X; National Center for Liver Cancer, Shanghai 200438, China.
  • Yan HX; BGI-Shenzhen, Shenzhen 518083, China.
  • Li WY; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Zeng X; National Center for Liver Cancer, Shanghai 200438, China.
  • Yang Y; BGI-Shenzhen, Shenzhen 518083, China.
  • Zhao J; School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China.
  • Liu SP; BGI-Shenzhen, Shenzhen 518083, China.
  • Zhuang XH; Faculty of Medicine, School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong 999077, China.
  • Lin C; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Qin CJ; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Zhao Y; BGI-Shenzhen, Shenzhen 518083, China.
  • Pan ZY; BGI-Shenzhen, Shenzhen 518083, China.
  • Huang G; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Liu H; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Zhang J; National Center for Liver Cancer, Shanghai 200438, China.
  • Wang RY; School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China.
  • Yang Y; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Wen W; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Lv GS; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Zhang HL; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Wu H; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Huang S; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Wang MD; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Tang L; National Center for Liver Cancer, Shanghai 200438, China.
  • Cao HZ; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Wang L; National Center for Liver Cancer, Shanghai 200438, China.
  • Lee TL; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Jiang H; National Center for Liver Cancer, Shanghai 200438, China.
  • Tan YX; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Yuan SX; National Center for Liver Cancer, Shanghai 200438, China.
  • Hou GJ; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Tao QF; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Xu QG; National Center for Liver Cancer, Shanghai 200438, China.
  • Zhang XQ; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
  • Wu MC; National Center for Liver Cancer, Shanghai 200438, China.
  • Xu X; BGI-Shenzhen, Shenzhen 518083, China.
  • Wang J; Department of Vascular and Endocrine Surgery, Xijing Hospital, Fourth Military Medical University, Xi An 710032, China.
  • Yang HM; Faculty of Medicine, School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong 999077, China.
  • Zhou WP; BGI-Shenzhen, Shenzhen 518083, China.
  • Wang HY; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China.
Nat Commun ; 7: 12992, 2016 10 05.
Article en En | MEDLINE | ID: mdl-27703150
ABSTRACT
Hepatitis B virus (HBV) can integrate into the human genome, contributing to genomic instability and hepatocarcinogenesis. Here by conducting high-throughput viral integration detection and RNA sequencing, we identify 4,225 HBV integration events in tumour and adjacent non-tumour samples from 426 patients with HCC. We show that HBV is prone to integrate into rare fragile sites and functional genomic regions including CpG islands. We observe a distinct pattern in the preferential sites of HBV integration between tumour and non-tumour tissues. HBV insertional sites are significantly enriched in the proximity of telomeres in tumours. Recurrent HBV target genes are identified with few that overlap. The overall HBV integration frequency is much higher in tumour genomes of males than in females, with a significant enrichment of integration into chromosome 17. Furthermore, a cirrhosis-dependent HBV integration pattern is observed, affecting distinct targeted genes. Our data suggest that HBV integration has a high potential to drive oncogenic transformation.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virus de la Hepatitis B / Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Female / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2016 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virus de la Hepatitis B / Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Female / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2016 Tipo del documento: Article País de afiliación: China